Search Results - "O’Hara, Daniel V."

Applications of SGLT2 inhibitors beyond glycaemic control by O’Hara, Daniel V., Lam, Carolyn S. P., McMurray, John J. V., Yi, Tae Won, Hocking, Samantha, Dawson, Jessica, Raichand, Smriti, Januszewski, Andrzej S., Jardine, Meg J.

“…Sodium–glucose cotransporter 2 (SGLT2) inhibitors were initially developed for their glucose-lowering effects and have shown a modest glycaemic benefit in…”
Get full text

The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes by O'Hara, Daniel V., Parkhill, Thomas R., Badve, Sunil V., Jun, Min, Jardine, Meg J., Perkovic, Vlado

“…Aims To summarize evidence from randomized controlled trials (RCTs) concerning the effects of dipeptidyl peptidase‐4 (DPP‐4) inhibitors on kidney outcomes in…”
Get full text

Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research by Yi, Tae Won, O'Hara, Daniel V, Smyth, Brendan, Jardine, Meg J, Levin, Adeera, Morton, Rachael L

“…Care gaps remain in modern health care despite the availability of robust, evidence-based medications. Although sodium-glucose cotransporter-2 (SGLT2)…”
Get full text

Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review by Worth, Hayley, O'Hara, Daniel V, Agarwal, Neeru, Collister, David, Brennan, Frank, Smyth, Brendan

“…People with kidney failure can experience a range of symptoms that lead to suffering and poor quality of life. Available therapies are limited, and evidence…”
Get full text

Digital health technologies to support medication adherence in chronic kidney disease by O'Hara, Daniel V., Yi, Tae Won, Lee, Vincent W., Jardine, Meg, Dawson, Jessica

“…Non‐adherence to medications is a critical challenge in the management of people with chronic kidney disease (CKD). This review explores the complexities of…”
Get full text

SGLT2 inhibitors may prevent diabetes by O’Hara, Daniel V., Jardine, Meg J.

“…Dapagliflozin reduces the risk of new-onset diabetes mellitus, according to results from a pre-specified pooled analysis of the DAPA-CKD and DAPA-HF trials…”
Get full text

Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care by O’Hara, Daniel V., Janse, Roemer J., Fu, Edouard L., Jardine, Meg J., Carrero, Juan-Jesus

“…To assess adherence and persistence to sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), and dipeptidyl…”
Get full text

Lessons for the clinical nephrologist: ureteric obstruction secondary to blood clot after kidney biopsy by O’Hara, Daniel V., Wong, Jeffrey K., Cooper, Bruce, Wong, Germaine, Wong, Muh Geot, Cheikh Hassan, Hicham Ibrahim

Get full text

A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab by Puri, Prianka, Hanxhiu, Anida, O'Hara, Daniel V, Hsu, Danny, Vucak-Dzumhur, Mirna

“…Pregnancy-related Atypical Haemolytic Uremic Syndrome (P-aHUS) is a rare condition affecting genetically predisposed women during pregnancy. It is often…”
Get full text

A Multinational, Multicenter Study Mapping Models of Kidney Supportive Care Practice by Marsh, Seren, Varghese, Amanda, Snead, Charlotte M., Hole, Barnaby D., O’Hara, Daniel V., Agarwal, Neeru, Stallworthy, Elizabeth, Caskey, Fergus J., Smyth, Brendan J., Ducharlet, Kathryn

“…Kidney supportive care (KSC) integrates kidney and palliative care to improve quality of life for people with chronic kidney disease (CKD). Despite increasing…”
Get full text